Pensioenfonds Zorg en Welzijn related stories
All articles and analysis
AlpInvest attracts 'several' biddersThe private equity giant, currently backed by Dutch pensions APG and PGGM, is being auctioned by Credit Suisse.
- AlpInvest looks to Africa
Already active in Latin America and Central and Eastern Europe, the Dutch limited partner is looking to take advantage of the investment opportunity in Africa, CEO Volker Doeksen said today in New York. The Netherlands-based investor pursues fund, secondary, co-investment and mezzanine opportunities.
- AlpInvest wins €2bn mezz mandate(3)
The €40 billion private equity investor has more than doubled its mezzanine mandate from its former pension fund parents, expanding its remit to include Europe and opening its London office.
- AlpInvest boosts secondaries team
Private equity investment behemoth AlpInvest has recruited a trio of secondaries specialists to strengthen its teams in New York and Amsterdam.
- Munsters swaps PGGM for ABP
The chief investment officer at Dutch pension fund PGGM will leave to become a director at one of Europe’s largest pension funds, ABP.
- Outward bound
Some of the world's most active limited partners are based in the Netherlands. What are they looking for in private equity? And is the asset class delivering? Colm Gilmore spoke to AlpInvest, Mn Services, Robeco and Wilshire
- 3i joins AlpInvest in German car company
Acquiring a minority stake in Novem Car Interior Design has pushed 3i's total investment in Germany this year to €270m.
- Alpinvest secures further pensions mandate
A €6bn mandate from Dutch pension funds ABP and PGGM has increased the firm’s assets under management to €20bn, reinforcing its position as Europe’s largest private equity manager.
- CVC, Goldman Sachs exit Novem
CVC Capital Partners and Goldman Sachs have realised their investment in the German car interior business, selling the business to AlpInvest Partners.
- NIB in E115m Belgian chemicals MBO
NIB Capital Private Equity has announced the purchase of specialty chemicals assets from UCB, a Belgian pharmaceuticals and chemicals business.